Liraglutide and renal outcomes in Type 2 diabetes: results of the 'Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results' (LEADER) trial

被引:2
|
作者
Poulter, N. [1 ]
Mann, J. F. E. [2 ]
Brown-Frandsen, K. [3 ]
Daniels, G. H. [4 ]
Kristensen, P. [3 ]
Nauck, M. A. [5 ]
Nissen, S. E. [6 ]
Pocock, S. [7 ]
Buse, J. B. [8 ]
Petrie, J. [9 ]
机构
[1] Imperial Coll London, Dept Physiol & Dis Prevent, London, England
[2] Friedrich Alexander Univ Erlangen, Erlangen, Germany
[3] Novo Nordisk AS, Bagsvaerd, Denmark
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[6] Cleveland Clin, Cleveland, OH 44106 USA
[7] London Sch Hyg & Trop Med, Med Stat Unit, London, England
[8] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[9] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
关键词
D O I
10.1111/dme.35_13304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A52
引用
收藏
页码:23 / 24
页数:2
相关论文
共 50 条
  • [1] Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER)
    Meier, J. J.
    Nitschmann, S.
    [J]. INTERNIST, 2017, 58 (03): : 303 - 305
  • [2] Follow the LEADER—Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial
    Sanjay Kalra
    [J]. Diabetes Therapy, 2016, 7 : 601 - 609
  • [3] Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
    Marso, Steven P.
    Poulter, Neil R.
    Nissen, Steven E.
    Nauck, Michael A.
    Zinman, Bernard
    Daniels, Gilbert H.
    Pocock, Stuart
    Steinberg, William M.
    Bergenstal, Richard M.
    Mann, Johannes F. E.
    Ravn, Lasse Steen
    Frandsen, Kirstine Brown
    Moses, Alan C.
    Buse, John B.
    [J]. AMERICAN HEART JOURNAL, 2013, 166 (05) : 823 - +
  • [4] Liraglutide and Renal Outcomes in Type 2 Diabetes: Results of the LEADER trial
    Mann, Johannes
    Nauck, Michael
    Jacob, Stephan
    Ludemann, Jorg
    Brown-Frandsen, Kirstine
    Rieck, Markus
    Daniels, Gilbert H.
    Kristensen, Peter
    Nissen, Steven E.
    Pocock, Stuart
    Poulter, Neil R.
    Ravn, Lasse S.
    Rasmussen, Soren
    Steinberg, William M.
    Stockner, Mette
    Zinman, Bernard
    Bergenstal, Richard M.
    Baeres, Florian M. M.
    Marso, Steve P.
    Buse, John B.
    [J]. INTERNIST, 2017, 58 : S8 - S8
  • [5] Liraglutide effect and action in diabetes: evaluation of cardiovascular outcome and results (LEADER) trial design and methods
    Marso, S. P.
    Poulter, N. R.
    Nissen, S. E.
    Nauck, M. A.
    Zinman, B.
    Pocock, S.
    Bergenstal, R. M.
    Mann, J. F. E.
    Ravn, L. S.
    Moses, A. C.
    Buse, J.
    [J]. DIABETOLOGIA, 2013, 56 : S37 - S37
  • [6] Follow the LEADER-Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial
    Kalra, Sanjay
    [J]. DIABETES THERAPY, 2016, 7 (04) : 601 - 609
  • [7] Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER™) Trial: Rationale and Study Design
    Bergenstal, Richard
    Daniels, Gilbert
    Mann, Johannes
    Nissen, Steven
    Pocock, Stuart
    Zinman, Bernard
    Buse, John
    Moses, Alan
    Zychma, Marcin
    Marso, Steven
    [J]. DIABETES, 2011, 60 : A612 - A613
  • [8] Severe hypoglycaemia, cardiovascular outcomes and death: Experience from the 'Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results' (LEADER) trial
    Bain, S.
    Zinman, B.
    Marso, S. P.
    Christiansen, E.
    Calanna, S.
    Rasmussen, S.
    Buse, J. B.
    [J]. DIABETIC MEDICINE, 2018, 35 : 11 - 11
  • [9] LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations
    Daniels, G. H.
    Hegedus, L.
    Marso, S. P.
    Nauck, M. A.
    Zinman, B.
    Bergenstal, R. M.
    Mann, J. F. E.
    Karsbol, J. Derving
    Moses, A. C.
    Buse, J. B.
    Tuttle, M.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (05): : 477 - 486
  • [10] Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease Results of the LEADER Trial
    Verma, Subodh
    Bhatt, Deepak L.
    Bain, Stephen C.
    Buse, John B.
    Mann, Johannes F. E.
    Marso, Steven P.
    Nauck, Michael A.
    Poulter, Neil R.
    Pratley, Richard E.
    Zinman, Bernard
    Michelsen, Marie M.
    Fries, Tea Monk
    Rasmussen, Soren
    Leiter, Lawrence A.
    [J]. CIRCULATION, 2018, 137 (20) : 2179 - 2183